Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.
about
Virology, Epidemiology and Pathology of Glossina Hytrosavirus, and Its Control Prospects in Laboratory Colonies of the Tsetse Fly, Glossina pallidipes (Diptera; Glossinidae)A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasisGenetic diversity and population structure of the secondary symbiont of tsetse flies, Sodalis glossinidius, in sleeping sickness foci in CameroonAn investigation into the protein composition of the teneral Glossina morsitans morsitans peritrophic matrixIn vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.An essential farnesylated kinesin in Trypanosoma brucei.Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets.Comparative gene expression of Wigglesworthia inhabiting non-infected and Trypanosoma brucei gambiense-infected Glossina palpalis gambiensis fliesParasitic infections in HIV infected individuals: diagnostic & therapeutic challengesFrom on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.The salivary secretome of the tsetse fly Glossina pallidipes (Diptera: Glossinidae) infected by salivary gland hypertrophy virus.Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs.Cell Surface Proteomics Provides Insight into Stage-Specific Remodeling of the Host-Parasite Interface in Trypanosoma bruceiEvolution and Structural Analyses of Glossina morsitans (Diptera; Glossinidae) Tetraspanins.Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.Assembly of the Trypanosoma brucei 60S ribosomal subunit nuclear export complex requires trypanosome-specific proteins P34 and P37.HIV-1/parasite co-infection and the emergence of new parasite strains.In vitro activity of salinomycin and monensin derivatives against Trypanosoma bruceiAn expression system to screen for inhibitors of parasite glucose transportersExcreted/secreted proteins from trypanosome procyclic strains.The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.Recent initiatives and strategies to developing new drugs for tropical parasitic diseases.Revisiting zoonotic human African trypanosomiasis control in Uganda.Multiple evolutionary origins of Trypanosoma evansi in Kenya.Trypanosoma brucei RNA binding proteins p34 and p37 mediate NOPP44/46 cellular localization via the exportin 1 nuclear export pathway.Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomibIn vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators.Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania.Functional expression and characterization of a purine nucleobase transporter gene from Leishmania major.Antitrypanosomal and cytotoxic activities of pyrrolizidine alkaloid-producing plants of Ethiopia.A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.Trypanosoma brucei: trypanocidal and cell swelling activities of lasalocid acid.Haematology of N'Dama and West African Shorthorn cattle herds under natural challenge in GhanaNovel lead compounds in pre-clinical development against African sleeping sicknessTrypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma bruceiProteases ofTrypanosoma brucei
P2860
Q24273309-23FBDFC2-FB16-4DDB-88FE-06775A176129Q26820381-14F37FDE-D714-42D5-9BD2-EB8FF881FD3BQ28476646-622276AE-51BA-47FA-AA68-EC2B9E47F822Q28538214-84804040-CB71-4379-9B26-E3DF89C2AE31Q33437657-C7AF2225-27B5-4818-A58A-0400DE0589C6Q34071572-60F95AEE-8E96-491D-988E-763274242E93Q34145529-0FCE7CD8-20B5-4CD0-90BE-7975E7B774B0Q34521842-2602C752-549C-4D87-A352-09BA2BBD093CQ34635675-1E3C7C2E-4B20-4B3C-A1D3-EBA540EE0873Q34775438-0BD3F0C7-5F65-487F-8179-EA33D4ABECC3Q35126176-3E854B00-EF53-425C-AD46-136D2BE9F8D1Q35189546-C8A8FF9A-7CE3-4B06-9FCE-3CCB31AE7878Q35568801-372A88F5-0628-4B19-BB1D-86335A5A7D88Q35840481-F5D6A9FC-9D0C-4E08-A69F-77B1D75EAA13Q36103902-B727AA6B-2F03-4D1D-BCE9-A7F6E32722FCQ36118572-57CB4BD1-1AE6-4BB0-9506-33C5AECED3FEQ36329959-748F890F-814A-4401-8E95-3A4A19D59CB6Q36369970-BC629661-A614-4CB1-9E16-FDB587E7C323Q37051206-6FEAA68F-EA47-4175-B9BC-4674ABEEE351Q37120966-94AB835B-8F57-44A3-8706-41FD4FA9CC28Q37149494-5F79B9D7-8370-4E74-8333-340FCF2F88B0Q37408643-0FBA4591-0E0B-4D8A-82D3-8C92813AAA8EQ37462293-639C05AD-F256-403A-A8CD-BBA08939865CQ37734328-C9CF6F65-1E05-4326-BF50-33C2698CD8F5Q38088306-FB2A54D8-282D-44F1-A64F-5880D4B53244Q38700778-6CD9F287-7B52-425F-9B2F-B6BCB982FE4EQ40053747-28BC803E-600D-49AB-888B-126311D69DF0Q40070898-61C13E95-2747-4C0E-9EFD-BF168F62F71CQ42559886-8AB89DB9-E55A-4BEC-BC76-129727B1FEF0Q43150669-C034F04D-A500-4A26-B152-50598EE83174Q43947251-6610E5A4-CA3A-4037-B9D7-1CB99E293E30Q44688252-DCE9CAF0-8CA2-44FA-A0D1-6BA02A370602Q45978245-B9EED5FB-FF83-4446-A010-701E836ECF4EQ46243733-BC0F272B-94A1-4222-8A9E-9F70D4E410D4Q47133878-9E4E1573-07F7-4AC7-BCA7-DC9B5910C65FQ57083168-65F4DBA8-3A26-4E41-8BAD-C3BB75CED474Q58842335-619C8F6C-A77D-4A20-89B0-E7CE844CFD7AQ58854975-3A22CF24-3108-4ED5-BA65-340D9264B443Q58854982-F3CA732F-C1E8-4C73-9A26-69660A4355A2
P2860
Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@ast
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@en
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@nl
type
label
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@ast
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@en
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@nl
prefLabel
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@ast
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@en
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@nl
P2093
P1476
Drug resistance in Trypanosoma ...... s in man and nagana in cattle.
@en
P2093
P304
P356
10.1016/S1286-4579(01)01432-0
P50
P577
2001-07-01T00:00:00Z